頁籤選單縮合
題名 | Reduction of Ventricular Hypertrophy and Fibrosis in Spontaneously Hypertensive Rats by L-Arginine |
---|---|
作者 | Chang, Huai-ren; Wu, Chia-yen; Hsu, Yung-hsiang; Chen, Hsing-i; | 書刊名 | 中國生理學雜誌 |
卷期 | 48:1 民94.03 |
頁次 | 頁15-22 |
分類號 | 397 |
關鍵詞 | L-arginin; Cyclic GMP; Nitric oxide; Cardiomyocytes; Ventricular hypertrophy; Fibrosis; |
語文 | 英文(English) |
英文摘要 | The purpose of this experiment was to explore long-term L-arginine administration on ventricular hypertrophy and cardiac fibrosis in spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) rats. Twenty-four rats of each strain at eight wks of age were divided into two groups-one receiving L-arginine and the other vehicle for twelve wks. Arterial pressure (AP) and heart rate were monitored. At 20 wks of age, the rats' rings of thoracic aorta were isolated to record isometric tension. The study measured left ventricular weight (LVW), body weight (BW), left ventricular (LV) contents of cGMP, and collagen volume fraction (LVCVF). Histological examination of the LV tissue determined changes in cardiomyocytes. Administration of L-arginine did not alter the AP change in SHR, but reduced the AP in WKY after six wks. Our results showed a significantly higher LVW/BW ratio and LVCVF in vehicle-treated SHR compared to levels in corresponding WKY, whereas, the LV cGMP and nitrite/nitrate measurements were higher in vehicle-treated WKY than in SHR. L-arginine treatment decreased LVW/BW ratio and LVCVF, while increasing the levels of LV cGMP and nitrite/ nitrate only in SHR, consistent with histopathological examinations that showed L-arginine prevented cardiomyocytes from thickness and hypertrophy. Our results suggested that the mechanism of reduction in ventricular hypertrophy and fibrosis following long-term L-arginine administration in SHR may stem from increased myocardial nitric oxide-cGMP signaling, independent of AP and EDV of thoracic aorta. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。